Literature DB >> 28793145

Role of Genetic Testing in Inherited Cardiovascular Disease: A Review.

Allison L Cirino1, Stephanie Harris1, Neal K Lakdawala1, Michelle Michels2, Iacopo Olivotto3, Sharlene M Day4, Dominic J Abrams5, Philippe Charron6, Colleen Caleshu7, Christopher Semsarian8, Jodie Ingles8, Harry Rakowski9, Daniel P Judge10, Carolyn Y Ho1.   

Abstract

Importance: Genetic testing is a valuable tool for managing inherited cardiovascular disease in patients and families, including hypertrophic, dilated, and arrhythmogenic cardiomyopathies and inherited arrhythmias. By identifying the molecular etiology of disease, genetic testing can improve diagnostic accuracy and refine family management. However, unique features associated with genetic testing affect the interpretation and application of results and differentiate it from traditional laboratory-based diagnostics. Clinicians and patients must have accurate and realistic expectations about the yield of genetic testing and its role in management. Familiarity with the rationale, implications, benefits, and limitations of genetic testing is essential to achieve the best possible outcomes. Observations: Successfully incorporating genetic testing into clinical practice requires (1) recognizing when inherited cardiovascular disease may be present, (2) identifying appropriate individuals in the family for testing, (3) selecting the appropriate genetic test, (4) understanding the complexities of result interpretation, and (5) effectively communicating the results and implications to the patient and family. Obtaining a detailed family history is critical to identify families who will benefit from genetic testing, determine the best strategy, and interpret results. Instead of focusing on an individual patient, genetic testing requires consideration of the family as a unit. Consolidation of care in centers with a high level of expertise is recommended. Clinicians without expertise in genetic testing will benefit from establishing referral or consultative networks with experienced clinicans in specialized multidisciplinary clinics. Conclusions and Relevance: Genetic testing provides a foundation for transitioning to more precise and individualized management. By distinguishing phenotypic subgroups, identifying disease mechanisms, and focusing family care, gene-based diagnosis can improve management. Successful integration of genetic testing into clinical practice requires understanding of the complexities of testing and effective communication of the implications to patients and families.

Entities:  

Mesh:

Year:  2017        PMID: 28793145     DOI: 10.1001/jamacardio.2017.2352

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  24 in total

Review 1.  [Genetic testing to prevent sudden cardiac death].

Authors:  B Stallmeyer; S Dittmann; E Schulze-Bahr
Journal:  Internist (Berl)       Date:  2018-08       Impact factor: 0.743

2.  Ability of Patients to Distinguish Among Cardiac Genomic Variant Subclassifications.

Authors:  Lydia D Hellwig; Barbara B Biesecker; Katie L Lewis; Leslie G Biesecker; Cynthia A James; William M P Klein
Journal:  Circ Genom Precis Med       Date:  2018-06

Review 3.  Practical Aspects in Genetic Testing for Cardiomyopathies and Channelopathies.

Authors:  Han-Chih Hencher Lee; Chor-Kwan Ching
Journal:  Clin Biochem Rev       Date:  2019-11

Review 4.  Family Communication About Genetic Risk of Hereditary Cardiomyopathies and Arrhythmias: an Integrative Review.

Authors:  Lisa L Shah; Sandra Daack-Hirsch
Journal:  J Genet Couns       Date:  2018-02-28       Impact factor: 2.537

5.  Hypertrophic Cardiomyopathy Gene Testing: Go Big?

Authors:  Megan J Puckelwartz; Elizabeth M McNally
Journal:  Circ Cardiovasc Genet       Date:  2017-10

6.  Linking Clinical Parameters and Genotype in Dilated Cardiomyopathy.

Authors:  Jared M Churko
Journal:  Circ Heart Fail       Date:  2018-11       Impact factor: 8.790

7.  Participatory Genomic Testing Can Effectively Disseminate Cardiovascular Pharmacogenomics Concepts within Federally Qualified Health Centers: A Feasibility Study.

Authors:  Amber Johnson; Stephen Broughton; Lisa Aponte-Soto; Karriem Watson; Carla Da Goia Pinto; Philip Empey; Steven Reis; Robert Winn; Mylynda Massart
Journal:  Ethn Dis       Date:  2020-04-02       Impact factor: 1.847

Review 8.  The Present and the Future of Genetic Testing in Familial Hypercholesterolemia: Opportunities and Caveats.

Authors:  Amanda J Hooper; John R Burnett; Damon A Bell; Gerald F Watts
Journal:  Curr Atheroscler Rep       Date:  2018-05-19       Impact factor: 5.113

9.  A Systematic Review of Discrete Choice Experiments and Conjoint Analysis on Genetic Testing.

Authors:  Semra Ozdemir; Jia Jia Lee; Isha Chaudhry; Remee Rose Quintana Ocampo
Journal:  Patient       Date:  2021-06-04       Impact factor: 3.883

Review 10.  Lethal Infectious Diseases as Inborn Errors of Immunity: Toward a Synthesis of the Germ and Genetic Theories.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Pathol       Date:  2020-04-14       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.